课题基金 / 基金详情

Assembly of Live Nipah Virus with Complement Factors

Assembly of Live Nipah Virus with Complement Factors
活尼帕病毒与补体因子的组装
批准号:
8896985
负责人:
Griffith D. Parks
金额:
$2.13万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-06-01 至 2015-05-31

项目摘要

项目成果

Griffith D. Parks的其他基金

相似基金

相关文献

中文摘要
翻译
补体系统是大多数动物病毒遇到的先天免疫反应的关键部分
英文摘要
The complement system is a critical part of innate immune responses that most animal viruses encounter during natural infections. While it is clear that complement (C') is an important factor in neutralization of some RNA viruses, very few mechanistic details are known about how C' regulates paramyxovirus infections. Here, we seek to fill gaps in understanding of interactions of complement (C') with the emerging highly pathogenic paramyxovirus Nipah virus (NiV). This project emerged from our recent published finding that: 1) complement is activated in vitro by pseudotypes containing the NiV F and G glycoproteins, but importantly, unlike any other paramyxovirus we have tested so far this does not result in neutralization. Our preliminary data also demonstrate that: 2) the cellular C' inhibitor Factor I protease associates with the NiV F but not HN protein and 3) Factor I associated with NiV pseudotypes can inactivate C3b by cleavage into iC3b. The novelty of the second and third findings is that no other pathogen has been reported so far to recruit Factor I as a mechanism to evade complement. In addition, support for our hypothesis would show a new function for the paramyxovirus F protein in evading innate immunity. In Aim 1, we will use biochemical approaches to test the hypothesis that functional human Factor I interacts specifically with the NiV F protein. Work in Aim 2 will involve studies with live NiV infection under Biosafety Level 4 (BSL4) conditions. We will determine the extent to which live NiV activates C' in vitro and the capacity of C' to neutralize NiV infectivity. In addition to recruitment of soluble Factor I, we hypothesize that NiV also captures cell surface inhibitors of C' such as CD46 and CD55. This will be tested using live NiV infection of tissue culture cells that express varying levels of inhibitors. This pilot project seeks to extend our novel findings from studies with NiV pseudotypes into live NiV under BSL-4 conditions, and to gain further supporting data for a novel mechanism of C' evasion. Both are necessary steps to establish a secure foundation for more mechanistic detailed studies with live virus and into experiments in animal models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Complement Resistance Acquired During Acute to Persistent Rubulavirus Infection
  • 批准号:
    10645486
  • 项目类别:
  • 资助金额:
    $24.12万
  • 财政年份:
    2023
  • 负责人:
    Griffith D. Parks
  • 依托单位:
Assembly of Live Nipah Virus with Complement Factors
Assembly of Live Nipah Virus with Complement Factors
Paramyxovirus Activation and Inhibition of Complement Pathways
国内基金
海外基金
虚拟集群Live迁移关键技术研究
  • 批准号:
    61170004
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2011
  • 负责人:
    魏晓辉
  • 依托单位: